Category: Consumer goods
Quick infos Headquarters: Austin, Texas, United States Trade prices Volume: Market Cap: 171.68M Prev closed: 16.68 Open: 16.54 High: 16.54 Low: 16.02 52 week low: 14.22 52 week high: 21.48 Dividends: No Dividends Next ER: May 10, 2023
Earnings History Date EPS / Forecast Revenue / Forecast May 10, 2023 March 1, 2023 -0.11 / -300.0K / -Beat! November 9, 2022 -0.42 / -1.68M / -Beat! August 23, 2022 -0.38 / -1.53M / -Beat! August 12, 2022 -0.38 / -1.53M / -Beat! view more
Historical Data Date Price Open High Low Vol Change ER May 9, 2022 6.36 6.88 6.96
6.35
144.61K -8.62% May 6, 2022 6.96 7.30 7.30
6.83
111.37K -4.79% May 5, 2022 7.31 7.79 7.79
7.25
110.62K -7.93% May 4, 2022 7.94 8.01 8.01
7.66
69.86K -1.12% May 3, 2022 8.03 7.72 8.06
7.26
185.23K 4.02% May 2, 2022 7.72 7.80 7.97
7.46
100.50K -0.52% Apr 29, 2022 7.76 8.26 8.55
7.68
127.79K -7.95% Apr 28, 2022 8.43 7.26 9.10
7.26
489.67K 16.44% Apr 27, 2022 7.24 7.29 7.51
7.21
127.92K -0.14% Apr 26, 2022 7.25 7.42 7.43
7.17
89.52K -2.95% view more
NASDAQ - Nasdaq Stock Market
News
XBIT, IMMR, ODT and INSG among after-hours movers seekingalpha.com Jul 7, 2021 5:32 am Xbiotech declares $2.50 special dividend seekingalpha.com Jul 7, 2021 4:47 am
XBiotech Announces Dividend to Holders of Common Stock finance.yahoo.com Jul 6, 2021 4:30 pm XBiotech received $75M from antibody sale of bermekimab seekingalpha.com Jul 1, 2021 12:13 am
XBiotech Inc (XBIT) falls -1.0510% for June 28 equities.com Jun 30, 2021 9:55 am
Is XBiotech Inc. (XBIT) Going to Burn These Hedge Funds? finance.yahoo.com Jun 29, 2021 8:04 am
Here's Why Shareholders May Want To Be Cautious With Increasing XBiotech Inc.'s (NASDAQ:XBIT) CEO Pay Packet nasdaq.com Jun 16, 2021 9:55 am
Shareholders May Not Be So Generous With XBiotech Inc.'s (NASDAQ:XBIT) CEO Compensation And Here's Why finance.yahoo.com Jun 16, 2021 2:52 am Here's What XBiotech Inc.'s (NASDAQ:XBIT) Shareholder Ownership Structure Looks Like finance.yahoo.com Jun 7, 2021 9:55 am Investors Who Bought XBiotech (NASDAQ:XBIT) Shares ... simplywall.st Jun 7, 2021 9:55 am
XBiotech To Test New Drug Candidate Combined With Approved Treatment In Pancreatic Cancer finance.yahoo.com Apr 19, 2021 7:08 am XBiotech: True Human Antibody Developer Needs More Candidates In The Clinic seekingalpha.com Mar 30, 2021
We're Not Very Worried About XBiotech's (NASDAQ:XBIT) Cash Burn Rate finance.yahoo.com Mar 18, 2021 7:51 am
XBiotech Candidate True Human COVID-19 Therapy Found to Target Highly Infectious Emerging Strain finance.yahoo.com Jan 21, 2021 8:15 am Is XBiotech Inc. (XBIT) A Good Stock To Buy? finance.yahoo.com Nov 29, 2020
Breakthrough Results from Phase 2 Clinical Trial of Bermekimab in the Treatment of Atopic Dermatitis (AD) to be Presented on March 2, 2019 at American Academy of Dermatology Annual Meeting finance.yahoo.com Oct 16, 2020 11:44 am
XBIT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of XBiotech, Inc. finance.yahoo.com Oct 16, 2020 9:36 am
XBiotech Announces Preliminary Results of Tender Offer finance.yahoo.com Oct 16, 2020 8:15 am
What Kind Of Shareholders Hold The Majority In XBiotech Inc.'s (NASDAQ:XBIT) Shares? finance.yahoo.com Sep 22, 2020 3:25 pm Enrollment underway in XBiotech's XB2001 study in pancreatic cancer seekingalpha.com Jun 23, 2021 8:37 pm This company doesn't provide a dividend.
Talk about XBiotech Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.
